Semnur Pharmaceuticals To Go Public Via $2.5B SPAC Merger

By Jade Martinez-Pogue · September 3, 2024, 1:26 PM EDT

Paul Hastings LLP-advised Semnur Pharmaceuticals Inc. on Tuesday unveiled plans to go public via a merger with Winston & Strawn LLP-led blank check company Denali Capital Acquisition Corp. in a deal...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login